中国医药导报
中國醫藥導報
중국의약도보
CHINA MEDICAL HERALD
2014年
28期
55-57,61
,共4页
龚敏%叶鑫%诸葛小寅%吴蔚
龔敏%葉鑫%諸葛小寅%吳蔚
공민%협흠%제갈소인%오위
速尿%低分子右旋糖酐%儿童%肾病综合征%水肿
速尿%低分子右鏇糖酐%兒童%腎病綜閤徵%水腫
속뇨%저분자우선당항%인동%신병종합정%수종
Furosemide%Low molecule dextran%Children%Nephrotic syndrome%Edema
目的:探讨低分子右旋糖酐联合速尿持续静滴治疗小儿肾病综合征水肿的临床效果。方法收集2013年1月~2014年1月衢州市人民医院收治的肾病综合征水肿患儿52例,随机将其分为观察组与对照组,每组各26例,两组均予以常规治疗,对照组应用速尿持续静滴,观察组则予以低分子右旋糖酐联合速尿持续静滴,比较两组的临床疗效。结果观察组的治疗总有效率为100.0%,显著高于对照组(80.8%),差异有统计学意义(P<0.05);水肿开始消退时间、血清白蛋白升高时间、多尿时间依次为(15.9±4.2)h、(7.8±1.1)d、(3.5±1.3)h,均较对照组[(28.4±12.3)h、(12.3±1.4)d、(14.3±2.9)h]显著缩短,差异均有统计学意义(P<0.05);治疗后两组的24 h尿蛋白及血清胆固醇均较治疗前显著降低,但观察组显著低于对照组,差异均有统计学意义(P<0.05);两组治疗后血清白蛋白水平均明显升高,但观察组显著高于对照组,差异有统计学意义(P<0.05);观察组停药后水肿复发率为7.7%,显著低于对照组(42.3%),差异有统计学意义(P<0.05)。结论低分子右旋糖酐联合用速尿持续静滴治疗小儿肾病综合征水肿效果显著,不良反应少,值得临床推广应用。
目的:探討低分子右鏇糖酐聯閤速尿持續靜滴治療小兒腎病綜閤徵水腫的臨床效果。方法收集2013年1月~2014年1月衢州市人民醫院收治的腎病綜閤徵水腫患兒52例,隨機將其分為觀察組與對照組,每組各26例,兩組均予以常規治療,對照組應用速尿持續靜滴,觀察組則予以低分子右鏇糖酐聯閤速尿持續靜滴,比較兩組的臨床療效。結果觀察組的治療總有效率為100.0%,顯著高于對照組(80.8%),差異有統計學意義(P<0.05);水腫開始消退時間、血清白蛋白升高時間、多尿時間依次為(15.9±4.2)h、(7.8±1.1)d、(3.5±1.3)h,均較對照組[(28.4±12.3)h、(12.3±1.4)d、(14.3±2.9)h]顯著縮短,差異均有統計學意義(P<0.05);治療後兩組的24 h尿蛋白及血清膽固醇均較治療前顯著降低,但觀察組顯著低于對照組,差異均有統計學意義(P<0.05);兩組治療後血清白蛋白水平均明顯升高,但觀察組顯著高于對照組,差異有統計學意義(P<0.05);觀察組停藥後水腫複髮率為7.7%,顯著低于對照組(42.3%),差異有統計學意義(P<0.05)。結論低分子右鏇糖酐聯閤用速尿持續靜滴治療小兒腎病綜閤徵水腫效果顯著,不良反應少,值得臨床推廣應用。
목적:탐토저분자우선당항연합속뇨지속정적치료소인신병종합정수종적림상효과。방법수집2013년1월~2014년1월구주시인민의원수치적신병종합정수종환인52례,수궤장기분위관찰조여대조조,매조각26례,량조균여이상규치료,대조조응용속뇨지속정적,관찰조칙여이저분자우선당항연합속뇨지속정적,비교량조적림상료효。결과관찰조적치료총유효솔위100.0%,현저고우대조조(80.8%),차이유통계학의의(P<0.05);수종개시소퇴시간、혈청백단백승고시간、다뇨시간의차위(15.9±4.2)h、(7.8±1.1)d、(3.5±1.3)h,균교대조조[(28.4±12.3)h、(12.3±1.4)d、(14.3±2.9)h]현저축단,차이균유통계학의의(P<0.05);치료후량조적24 h뇨단백급혈청담고순균교치료전현저강저,단관찰조현저저우대조조,차이균유통계학의의(P<0.05);량조치료후혈청백단백수평균명현승고,단관찰조현저고우대조조,차이유통계학의의(P<0.05);관찰조정약후수종복발솔위7.7%,현저저우대조조(42.3%),차이유통계학의의(P<0.05)。결론저분자우선당항연합용속뇨지속정적치료소인신병종합정수종효과현저,불량반응소,치득림상추엄응용。
Objective To investigate the clinical efficacy of low molecule dextran combined with furosemide continuous infusion for the treatment of children with nephrotic syndrome. Methods 52 cases of children with nephrotic syndrome from January 2013 and January 2014 in the People's Hospital of Quzhou City in Zhejiang Province were collected. The children were divided into observation group and control group randomly, with 26 cases in each group. The two groups were received routine treatment, and the control group were given urosemide continuous infusion, the observation group were given low molecule dextran combined with furosemide continuous infusion. The clinical efficacy of the two groups were compared. Results The total effective rate of observation group was 100.0%, significantly higher than that in the control group (80.8%), the difference was statistically significant (P< 0.05); the time of swelling began to subside, ele-vated serum albumin, and polyuria of observation group were (15.9±4.2) h, (7.8±1.1) d, (3.5±1.3) h respectively, which were significantly shorter than those of the control group [(28.4±12.3) h, (12.3±1.4) d, (14.3±2.9) h], the differences were statistically significant (P< 0.05). After treatment, the 24 h urine protein and serum cholesterol in the two groups were significantly reduced compared with before treatment, and the observation group were lower than those of the con-trol group, the differences were statistically significant (P<0.05); the serum albumin levels of the two groups were sig-nificantly elevated, but the observation group was significantly higher than the control group, the difference was statisti-cally significant (P< 0.05). After discontinuation, the edema relapse of the observation group was 7.7%, significantly lower than that in the control group (42.3%), the difference was statistically significant (P<0.05). Conclusion The low molecule dextran combined with furosemide continuous infusion for the treatment of children with nephrotic syndrome has a significant effect and fewer adverse reactions, it is worthy of clinical application.